Allina reported revenues of $1.05 billion in the third quarter of this year, up from $1.01 billion in the same period of 2017, according to recently released bondholder documents. The boost was attributable to higher net patient service revenue, which climbed nearly 5 percent year over year.
The system’s operating expenses totaled $1.03 billion in the third quarter of 2018, up from $981.4 million in the same period a year earlier.
Allina ended the third quarter of this year with operating income of $26.4 million. That’s down 9 percent from the third quarter of 2017, when the system reported operating income of $29.1 million.
Allina reported an investment return of $44.9 million in the third quarter of 2017, but that number dipped to $22.4 million in the third quarter of this year.
After factoring in the drop in investment income, Allina’s net income tumbled 30 percent year over year to $50.1 million in the third quarter of 2018.
More articles on healthcare finance:
9 hospitals with strong finances
Private equity pushes into healthcare: 6 latest deals
How CHS, Tenet, HCA, LifePoint and UHS fared in Q3
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
